Chris Liddle BSc(Med), MB.BS, PhD, FRACP, is an academic physician and Professor of Clinical Pharmacology and Hepatology, University of Sydney and Westmead Hospital, Sydney, Australia. He completed his undergraduate degrees at the University of NSW and physician training in Gastroenterology in 1985. PhD studies were undertaken at the University of Sydney, followed by post-doctoral studies at the Karolinska Institute, Stockholm, Sweden
He is head of the Department of Clinical Pharmacology at Westmead Hospital and a principal investigator within the Storr Liver Centre, Westmead Institute for Medical Research. His clinical interests span hepatology, toxicology and clinical pharmacology. Chris’ main area of research has been the functional genomics of metabolism and liver diseases, utilizing recent technological developments in DNA sequencing and bioinformatics in order to elucidate new drug targets in areas of high therapeutic need. This includes diseases such as diabetes, fatty liver disease, cholestatic liver diseases, liver fibrosis and pancreatic cancer. Much of this work has been performed in collaboration with the Salk Institute in San Diego, where he was appointed an adjunct professor in 2010. His research has led to many high impact publications as well as several patent families.